Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rabinovich

Showing results (1-10 of 482) with videos related to

Pageof 49
Sort By:
British Journal of Cancer|March 24, 2005
Galectin-1 as a potential cancer targetG A Rabinovich
Cell Death and Differentiation|September 1, 1999
Galectins: an evolutionarily conserved family of animal lectins with multifunctional properties; a trip from the gene to clinical therapyG A Rabinovich
Memorias Do Instituto Oswaldo Cruz|January 6, 2001
Apoptosis as a target for gene therapy in rheumatoid arthritisG A Rabinovich
Aviakosmicheskaia I Ekologicheskaia Meditsina = Aerospace and Environmental Medicine|April 5, 2007
[Viscously-elastic properties of brain and loss of consciousness by human under acceleration]B A Rabinovich
European Journal of Gynaecological Oncology|August 3, 2004
Gemcitabine in heavily pretreated patients with recurrent ovarian, peritoneal and fallopian tube carcinomaB Piura, A Rabinovich
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 15, 2005
Topotecan in heavily pretreated patients with recurrent ovarian, peritoneal, and fallopian tube carcinomaB Piura, A Rabinovich
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 28, 2000
Primary carcinoma of the fallopian tube: study of 11 casesB Piura, A Rabinovich
European Journal of Gynaecological Oncology|July 5, 2005
Doxorubicin and ifosfamide-mesna in advanced and recurrent uterine sarcomasB Piura, A Rabinovich
Current Opinion in Hematology|September 14, 2011
Galectins and microenvironmental niches during hematopoiesisGabriel A Rabinovich, Michel Vidal
Journal of Thrombosis and Haemostasis : JTH|November 19, 2016
The postthrombotic syndrome: current evidence and future challengesA Rabinovich, S R Kahn
Pageof 49

Showing results (1-10 of 482) with videos related to

Sort By:
Pageof 49
British Journal of Cancer|March 24, 2005
Galectin-1 as a potential cancer targetG A Rabinovich
Cell Death and Differentiation|September 1, 1999
Galectins: an evolutionarily conserved family of animal lectins with multifunctional properties; a trip from the gene to clinical therapyG A Rabinovich
Memorias Do Instituto Oswaldo Cruz|January 6, 2001
Apoptosis as a target for gene therapy in rheumatoid arthritisG A Rabinovich
Aviakosmicheskaia I Ekologicheskaia Meditsina = Aerospace and Environmental Medicine|April 5, 2007
[Viscously-elastic properties of brain and loss of consciousness by human under acceleration]B A Rabinovich
European Journal of Gynaecological Oncology|August 3, 2004
Gemcitabine in heavily pretreated patients with recurrent ovarian, peritoneal and fallopian tube carcinomaB Piura, A Rabinovich
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 15, 2005
Topotecan in heavily pretreated patients with recurrent ovarian, peritoneal, and fallopian tube carcinomaB Piura, A Rabinovich
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 28, 2000
Primary carcinoma of the fallopian tube: study of 11 casesB Piura, A Rabinovich
European Journal of Gynaecological Oncology|July 5, 2005
Doxorubicin and ifosfamide-mesna in advanced and recurrent uterine sarcomasB Piura, A Rabinovich
Current Opinion in Hematology|September 14, 2011
Galectins and microenvironmental niches during hematopoiesisGabriel A Rabinovich, Michel Vidal
Journal of Thrombosis and Haemostasis : JTH|November 19, 2016
The postthrombotic syndrome: current evidence and future challengesA Rabinovich, S R Kahn
Pageof 49